Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis
Aventix Medical Inc. · NCT06598319
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–85 · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 30
- US sites recruiting
- 3
- Study start
- November 15, 2024
- Record last updated
- April 30, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Evaluation of safety, effectiveness and tolerability of the Aventix Medical Device used for the treatment of chronic rhinitis
Being studied: NOVOCLEAR™ Device
Conditions: Chronic Rhinitis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- The subject is 18 to 85 years of age.
- The subject has had symptoms of chronic rhinitis for greater than 6 months with insufficient response to nasal steroids.
- The subject has an rTNSS total score of ≥ 6.
- The subject has had moderate to severe symptoms of rhinorrhea and/or nasal congestion (rTNSS rating of 2 or 3 for rhinorrhea and 1, 2, or 3 for congestion)
- The subject is able and willing to provide written informed consent and comply with the protocol requirements.
Exclusion Criteria
- The subject has clinically significant anatomic obstructions on either side that limit access to the posterior nose, including severe septal deviation, nasal polyps, and sinonasal tumor
- The subject has a septal perforation
- The subject has had prior sinus or nasal surgery on either side that significantly alters the anatomy of the posterior nose.
- The subject had had previous surgery of the PNN for chronic rhinitis.
- The subject has had prior head or neck irradiation
- The subject has an active or chronic nasal or sinus infection
- The subject has active coagulation disorder, or the patient is receiving anticoagulants
- The subject has a history of dry eye or dry nose symptoms
- Patient has rhinitis medicamentosa
- The subject has ocular allergic symptoms
- The subject has a history of nose bleeds
- The subject has electrically sensitive implants (e.g. cochlear implants, pacemakers, defibrillators)
- The subject is pregnant or lactating
- The subject is participating in another clinical research study
- The subject has an allergy or intolerance to anesthetic agent
- Any physical condition that, in the Investigator's opinion, would prevent adequate study participation or pose an increased risk
Recruiting US locations
Colorado ENT and Allergy
Colorado Springs, CO 80923
Site contact: Monica Davis · (719) 867-7804
Bay Area ENT
Ocean Springs, MS 39564
Site contact: Raymond Weiss, MD
Atkins Expert Sinus Care
San Antonio, TX 78256
Site contact: James Atkins, MD
Study contacts (from the official record)
- ClinicalAdmin · (510) 912-2589 · clinical@aventixmed.com